impact:

biolegend.com

BioLegend is a global developer and manufacturer of antibodies and reagents used in biomedical research located in San Diego, California. It was incorporated in June 2002 and has since expanded to include BioLegend Japan KK, where it is partnered with Tomy Digital Biology Co., Ltd. in Tokyo, BioLegend Europe in the United Kingdom, BioLegend GmbH in Germany, and BioLegend UK Ltd in the United Kingdom. BioLegend manufactures products in the areas of neuroscience, cell immunophenotyping, cytokines and chemokines, adhesion, cancer research, T regulatory cells, stem cells, innate immunity, cell-cycle analysis, apoptosis, and modification-specific antibodies. Reagents are created for use in flow cytometry, proteogenomics, ELISA, immunoprecipitation, Western blotting, immunofluorescence microscopy, immunohistochemistry, and in vitro or in vivo functional assays. More information...

According to PR-model, biolegend.com is ranked 516,132nd in multilingual Wikipedia, in particular this website is ranked 292,666th in English Wikipedia.

The website is placed before sita.co.uk and after smallsrecords.com in the BestRef global ranking of the most important sources of Wikipedia.

#Language
PR-model F-model AR-model
516,132nd place
661,443rd place
550,200th place
292,666th place
479,905th place
386,494th place
daDanish
24,977th place
38,495th place
14,526th place
77,087th place
108,016th place
125,479th place
439,125th place
362,207th place
370,952nd place
arArabic
247,036th place
135,435th place
102,249th place
90,136th place
47,306th place
89,403rd place